Gene: BHLHE41
Official Full Name: basic helix-loop-helix family member e41provided by HGNC
Gene Summary: This gene encodes a basic helix-loop-helix protein expressed in various tissues. The encoded protein can interact with ARNTL or compete for E-box binding sites in the promoter of PER1 and repress CLOCK/ARNTL's transactivation of PER1. This gene is believed to be involved in the control of circadian rhythm and cell differentiation. Defects in this gene are associated with the short sleep phenotype. [provided by RefSeq, Feb 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19447 | BHLHE41 Knockout cell line (HCT 116) | Human | BHLHE41 | 1:2~1:4 | Negative | Online Inquiry |
KO19448 | BHLHE41 Knockout cell line (HEK293) | Human | BHLHE41 | 1:3~1:6 | Negative | Online Inquiry |
BHLHE41 Gene Knockout Cell Lines are engineered cellular models designed to facilitate the study of the BHLHE41 gene, known for its role as a transcriptional regulator involved in various biological processes, including circadian rhythm regulation and metabolic homeostasis. By employing CRISPR/Cas9 technology, these cell lines have been meticulously created to disrupt the BHLHE41 gene function, enabling researchers to investigate the downstream effects of gene knockout on cellular pathways and physiological responses.
The primary mechanism of action of these knockout cell lines involves the introduction of specific mutations within the BHLHE41 gene, resulting in the loss of functional protein expression. This allows for a comprehensive assessment of the gene's influence on critical processes such as sleep-wake cycles, hormonal regulation, and cellular proliferation. By utilizing the BHLHE41 Gene Knockout Cell Lines, researchers are equipped to explore the gene's role in various pathologies, including obesity, diabetes, and sleep disorders, advancing our understanding of these complex conditions.
The scientific importance of these cell lines lies in their potential applications in both research and clinical settings. In basic research, they offer insights into the molecular mechanisms by which BHLHE41 contributes to gene regulation and cellular function. Clinically, they can aid in the development of novel therapeutic strategies targeting the pathways influenced by BHLHE41, leading to better management of disorders linked to its dysregulation.
Compared to alternative models, such as wild-type cell lines or those utilizing other knockout methods, BHLHE41 Gene Knockout Cell Lines present unique advantages, including enhanced specificity in gene disruption and the ability to study BHLHE41's role in a defined genetic background. This specificity reduces the likelihood of off-target effects, ensuring more reliable and reproducible results in experimental research.
For researchers and clinicians alike, the value of the BHLHE41 Gene Knockout Cell Lines cannot be overstated. They offer a powerful tool for elucidating fundamental biological mechanisms, paving the way for breakthroughs in treatment and understanding of genetically influenced diseases.
Our company, with its commitment to leading-edge biotechnology, provides high-quality biological products backed by rigorous scientific validation, ensuring that researchers have the necessary tools to advance their work and achieve impactful discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.